Oncology News | pharmaphorum

News

Six golden stars over black background. 3D illustration of high quality customer service

21GRAMS and McCann Health take top spot at PM Society Awards...

After two years of virtual events, the PM Society celebrated its 36th annual awards with an in-person ceremony at London’s Grosvenor House on Friday 11 March.

News

AZ, Merck get FDA okay for Lynparza as adjuvant breast cance...

The FDA has cleared AstraZeneca and Merck & Co's Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending its lead over pretenders to its PARP inhibitor crown.

News

Chasing rivals, Bayer files Nubeqa for new prostate cancer u...

Bayer has filed for approval to extend the use of its prostate cancer therapy Nubeqa as it tries to achieve labelling parity with rival drugs from Pfizer/Astellas and Johnson & Jonson,

News

New bill moves to tighten accelerated approval regulation in...

US House Energy & Commerce Committee Chair Frank Pallone (D-NJ) has introduced a new bill to enhance the Food and Drug Administration’s (FDA) authority to ensure products that receive a

News

The data are in – so will Gilead's Trodelvy achieve its pote...

The results of Gilead's much-anticipated TROPiCS-02 study of Trodelvy are in, and while the company says top-line data are positive, its guarded stance has rung some alarm bells.

News

BMS carves out a neoadjuvant niche for Opdivo in NSCLC

Bristol-Myers Squibb's Opdivo has been playing second fiddle to Merck & Co's Keytruda in the non-small cell lung cancer (NSCLC) market for years, but now it has a chance to take the lim

21GRAMS and McCann Health take top spot at PM Society Awards...

AZ, Merck get FDA okay for Lynparza as adjuvant breast cance...

Chasing rivals, Bayer files Nubeqa for new prostate cancer u...

New bill moves to tighten accelerated approval regulation in...

The data are in – so will Gilead's Trodelvy achieve its pote...

BMS carves out a neoadjuvant niche for Opdivo in NSCLC

Bayer bags FDA green light for stroke drug Sunharbo

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks